Table 6.

Effect of phenotype severity in heterozygous familial hypercholesterolemia on type 2 diabetes prevalence.

Comparison	All	HeFH with LDL <250 mg/dL	HeFH with LDL ≥250 mg/dL	HeFH with >8 points
Odds ratio (95% CI) Unadjusted	0.821 (0.429–1.572)	0.736 (0.287–1.887)	2.384 (0.557–10.207)	0.707 (0.294–1.696)
Odds ratio (95% CI) Adjusted*	0.954 (0.488–1.866)	1.386 (0.498–3.852)	2.395 (0.549–10.444)	0.747 (0.303–1.839)
Odds ratio (95% CI) Adjusted†	0.936 (0.478–1.835)	1.388 (0.496–3.887)	2.806 (0.631–12.478)	0.735 (0.298–1.813)
Odds ratio (95% CI) Adjusted‡	1.072 (0.533–2.155)	1.474 (0.512–4.243)	3.056 (0.670–13.930)	0.877 (0.341–2.250)

^*Adjusted for age, sex and years of statin use.

^†Adjusted for age, sex, years of statin use and body mass index.

^‡Adjusted for age, sex, years of statin use, body mass index, triglycerides, and hypertension.